AWM
AGIO icon

Avior Wealth Management’s Agios Pharmaceuticals AGIO Stock Holding History

Avior Wealth Management’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-11
Closed -$321 – 2286
2024
Q1 		$321 Buy
+11
New +$295 ﹤0.01% 2701
2019
Q3 		– Sell
-4,900
Closed -$244K – 768
2019
Q2 		$244K Buy
4,900
+1,620
+49% +$86.6K 0.04% 331
2019
Q1 		$221K Buy
3,280
+2,716
+482% +$158K 0.05% 327
2018
Q4 		$26K Hold
564
– – 0.01% 506
2018
Q3 		$43K Buy
+564
New +$45.4K 0.01% 492

Other funds holding AGIO

FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Avior Wealth Management's AGIO Position: Q2 2024 in Review

Avior Wealth Management sold out of Agios Pharmaceuticals (AGIO) in Q2 2024, closing a stake of 11 shares — an estimated $321 sold.

Avior Wealth Management first reported a position in AGIO in Q3 2018 and held it in 5 quarters. The position peaked at $244K in Q2 2019. 206 funds tracked by Wall St. Rank hold AGIO as of Q2 2024.

  • Avior Wealth Management reported no remaining Agios Pharmaceuticals position as of Q2 2024 after selling out during the quarter.
  • Avior Wealth Management sold 11 Agios Pharmaceuticals shares in Q2 2024, an estimated $321.
  • Avior Wealth Management first reported a position in Agios Pharmaceuticals in Q3 2018 and held it in 5 quarters.
  • Avior Wealth Management's Agios Pharmaceuticals position peaked at $244K in Q2 2019.
  • 206 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q2 2024.

Based on Avior Wealth Management's 13F filing for Q2 2024, filed 13 Aug 2024.